Welcome to the latest edition of the ADNeT newsletter.
We are on the cusp of significant progress in new drugs and blood tests for preventing, diagnosing and treating dementia. It is a critical time to support the research driving these innovations. At this end of the financial year, your tax deductible donation will advance dementia research and directly contribute to world-leading innovation in dementia diagnosis and treatment. Together, we can improve lives today and help change the future of dementia for generations to come.
In this issue, we highlight the exciting progress being made across dementia research in Australia, with a strong focus on improving early detection, and clinician education.
You’ll hear from Dr Stephanie Daly, GP, advocate for better dementia education, as she discusses the critical role GPs should play in early intervention of Alzheimer’s disease and ADNeT’s latest research on blood-based biomarker testing for early, accurate and efficient diagnosis.
As disease-modifying therapies (DMTs) continue to be approved and trialled worldwide, ADNeT partners will continue to advocate for their approval in Australia. The European Commission recently reversed their decision to reject lecanemab, to allow the treatment to be administered with strict conditions. A new drug remternetug, is seeking participants for a new study which will also target amyloid build-up. You can read more about that here as we welcome more DMTs being trialled in Australia.
ADNeT Chief Investigtor and Co-Director of the Centre for Healthy Brain Ageing, Henry Brodaty AO, will address the National Press Club in July, highlighting the importance of dementia being a nationwide and important topic, and underscoring the need for Australians to maintain their brain health in order to delay or offset progression of dementia. You can find details of the event here and further in the newsletter.
We also spotlight new international insights from the Alzheimer’s Association 2025 Facts and Figures report, which reinforces the importance of early detection and diagnostic innovation—an area where ADNeT continues to lead groundbreaking research.
Finally, with the Australian Dementia Research Forum 2025 fast approaching, we invite you to register and explore this year’s theme: The Future of Dementia Prevention, Research and Care. With symposia, keynote speakers, and CPD sessions, it promises to be a forum not to miss.
I hope you find the newsletter informative. You can read it in full here
Professor Chris Rowe, Director, ADNeT